Burning Rock Received FDA Breakthrough Device Designation for its OverC™ Multi-Cancer Detection Blood Test

/PRNewswire/ -- Burning Rock (NASDAQ/LSE: BNR), a company focused on the application of next generation sequencing (NGS) technology in the field of precision...

Related Keywords

China , Yusheng Han , Breakthrough Devices Program , Drug Administration , Multi Cancer Detection Blood Test , Breakthrough Device Designation , Devices Program , Nature Biomedical , Burning Rock , Device Designation ,